(351 days)
Not Found
No
The device description and performance studies focus on physical containment, filtration, and structural integrity, with no mention of AI/ML technologies.
No
The device is designed to prevent chemical and particulate cross-contamination between a contaminated patient and the external environment during transport. It does not treat or cure any medical condition.
No
This device is a patient isolation unit designed to prevent cross-contamination during transport, not to diagnose medical conditions.
No
The device description clearly outlines a physical, tubular, flexible Patient Isolation Unit with windows, glove arms, a reinforced base mat, carry straps, tethers, exhaust ports, and filter cartridges. It also mentions performance testing involving physical attributes like hoisting, transport, permeation, liquid penetration, and weight lift capacity. There is no mention of software as a component or the primary function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to prevent cross-contamination during patient transport and evacuation. This is a physical containment function, not a diagnostic test performed on biological samples.
- Device Description: The description details a physical enclosure with features for patient monitoring and airflow, not equipment for analyzing biological specimens.
- Lack of IVD-related information: There is no mention of analyzing samples, detecting analytes, or providing diagnostic information.
- Performance Studies: The performance studies focus on physical properties like containment efficiency, liquid penetration, comfort, and weight capacity, which are relevant to a containment device, not an IVD.
- Predicate Device: The predicate device (K052798; CAPSULS Patient Isolation Unit) is also a patient isolation unit, further supporting that this device falls under the category of patient containment/transport, not in vitro diagnostics.
In vitro diagnostics are tests performed on samples taken from the human body (like blood, urine, or tissue) to detect diseases, conditions, or infections. This device does not perform such tests.
N/A
Intended Use / Indications for Use
The Model ORCA-2016CN is a portable and ambulatory Patient Isolation Unit (PIU) designed to prevent chemical and particulate (biological and radiological) cross-contamination between an enclosed contaminated patient and the external environment during evacuation and transport activities.
Product codes
LGN
Device Description
The Operational Rescue Containment Apparatus (ORCA™) Patient Isolation Unit, Model ORCA-2016CN, is a tubular, flexible, Patient Isolation Unit (PIU) for use during transport and evacuation of chemical and particulate (biological and radiological) contaminated patients who have been medically stabilized. Each unit employs clear windows to allow visual monitoring of the patient. The unit incorporates multiple glove arms for minimal medical intervention.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
The device is used by trained medical personnel, who may or may not be licensed physicians or surgeons, and who may or may not be operating the device under the supervision of such licensed medical professionals. For this reason, ISOVAC Products intends that the ORCA™ be cleared for over-the-counter use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Operation system testing was successfully conducted on the ORCA™ PIU by the U.S. Coast Guard. This operational testing included hoisting and transport of the PIU with the test platform being a MH-60 helicopter. The PIU was hoisted multiple times at various altitudes (25/50/75/100 ft.) using a trail line to stabilize the stokes litter (video documentation is on file with the USCG). The results from this performance testing, to the satisfaction of the USCG, validated the "proof of concept" for using the PIU in USCG aircraft. The MH-60 generates 90 plus knots of downward rotor wash during a hover and this was deemed by the USCG as sufficient testing as the PIU is intended to be a one time use piece of equipment. USCG Tactics, Techniques and Procedures (TTP) for operational use of the PIU clearly articulates this requirement/limitation of the PIU. This includes the maximum flight duration allowed, DECON, training and maintenance. While a small boat could be used for transport of the PIU, the current CONOP uses a helicopter as this is the most extreme condition and most likely in the event we are transporting a contaminated patient.
Performance system testing was successfully conducted on the ORCA™ PIU by a third-party testing party under contract with the USGC. This performance testing included Chemical Agent Permeation (HD (distilled mustard) and GD (soman)), Liquid Penetration / Pathogen Passage, Human Use Comfort, and Weight Lift Testing.
PIU system permeation testing was performed in principle to those methods described in Institute of Environmental Sciences and Technology IEST- RP-CC001.3 (Ref 2) and MIL-STD-282 Method 102.9.1 (Ref 3) and demonstrated a containment efficiency (%) for both aerosols at a maximum 0.3 micron particle size exceeded the objective requirement. Liquid Penetration / Pathogen Passage testing was performed using methods described in ASTM F1671/F1671M-13: Standard Test Method for Resistance of Materials Used in Protective Clothing to Penetration by Blood-Borne Pathogens Using Phi-X174 Bacteriophage Penetration as a Test System. No detectable bacteriophage in the assay titer (i.e., 0 PFU/mL) was considered passing. The Bag Seam, Sleeve Seam, and Window Seam three materials passed liquid penetration testing.
Human interface comfort testing was performed using a test participant (TP) while being contained in the PIU for four hours. The participant was exposed to a matrix of six (6) temperature and RH% environments ranging from 65-90°F and 40 - 90% in a wind speed of 4 mph. Internal PIU temperature, RH%, CO2 and O2 levels, as well patient vitals and comfort levels were monitored over the four-hour test duration. The TP's vital signs were stable for the duration of the test with no indication of any heat stress or health related issue. Additionally, the TP reported no significant problems throughout the duration of the test.
The PIU weight lift capacity was tested under ISOVAC standard protocol procedure. The testing demonstrated the PIU handle strapping can hold the maximum test load of 480lb or a load of 137% of the stated maximum.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5450 Patient care reverse isolation chamber.
(a)
Identification. A patient care reverse isolation chamber is a device consisting of a roomlike enclosure designed to prevent the entry of harmful airborne material. This device protects a patient who is undergoing treatment for burns or is lacking a normal immunosuppressive defense due to therapy or congenital abnormality. The device includes fans and air filters which maintain an atmosphere of clean air at a pressure greater than the air pressure outside the enclosure.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a series of human profiles.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 2, 2017
ISOVAC Products, LLC % Jeffery Jones Consultant JL Jones Group, Inc 1213 Kevington Drive Antioch, Illinois 60002
Re: K163223
Trade/Device Name: ORCA™ - Operational Rescue Containment Apparatus Regulation Number: 21 CFR 880.5450 Regulation Name: Patient Care Reverse Isolation Chamber Regulatory Class: Class II Product Code: LGN Dated: September 29, 2017 Received: October 4, 2017
Dear Jeffery Jones:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Michael J. Ryan -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K163223
Device Name
ORCA (tm) - Operational Rescue Containment Apparatus
Indications for Use (Describe)
The Model ORCA-2016CN is a portable and ambulatory Patient Isolation Unit (PIU) designed to prevent chemical and particulate (biological and radiological) cross-contamination between an enclosed contaminated patient and the external environment during evacuation and transport activities.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image shows the logo for ISOVAC Products LLC. The logo consists of the company name in green text. To the left of the company name is a circular graphic with the letters ISOVAC inside.
1306 Enterprise Drive, Unit C • Romeoville, IL 60446 • 630-679-1740
510(k) Summary
Submitter's Name: ISOVAC Products, LLC 1306 Enterprise Drive, Unit C Romeoville, IL 60446 Telephone: (630) 679-1740 Fax: (630) 679-1750 E-mail: pjenkner@isovacproducts.com
Contact person: Mr. Jeffery Jones, Consultant
Date of Summary: October 31, 2017
Device Names:
Trade Name: ORCA™ - Operational Rescue Containment Apparatus Common Name: Patient Isolation Unit (PIU) Regulation Name: Patient care reverse isolation chamber Classification Name: Class II (21 CFR 880.5450) Product Code: LGN
Predicate Device:
The legally marketed predicate device is the CAPSULS Patient Isolation Unit (K052798) manufactured by ISOVAC Products. -
Device Description:
The Operational Rescue Containment Apparatus (ORCATM) Patient Isolation Unit, Model ORCA-2016CN, is a tubular, flexible, Patient Isolation Unit (PIU) for use during transport and evacuation of chemical and particulate (biological and radiological) contaminated patients who have been medically stabilized. Each unit employs clear windows to allow visual monitoring of the patient. The unit incorporates multiple glove arms for minimal medical intervention.
4
Image /page/4/Picture/1 description: The image shows the logo for ISOVAC Products LLC. The logo consists of the company name in green text, with the word "ISOVAC" in a bold, sans-serif font and "Products LLC" in a smaller font below it. To the left of the name is a circular graphic with the letters "ISOVAC" inside.
1306 Enterprise Drive, Unit C • • Romeoville, IL 60446 • • 630-679-1740
The PIU's have a reinforced base mat with integrated carry straps and tethers to enable lifting and attachment to a Stokes litter for hoisting operations or a North Atlantic Treaty Organization (NATO) litter for alternative transportation. Chamber airflow through the isolator and across the patient is provided by the blower from a Powered Air-Purifying Respirator (PAPR). Internal contaminated air in the PIU is vented out the exhaust ports which are fitted with two Chemical, Biological, Radiological, Nuclear (CBRN) filter cartridges, thus protecting the external environment from a contaminated patient.
The device is used by trained medical personnel, who may or may not be licensed physicians or surgeons, and who may or may not be operating the device under the supervision of such licensed medical professionals. For this reason, ISOVAC Products intends that the ORCA™ be cleared for over-the-counter use.
Indications for Use:
The Model ORCA-2016CN is a portable and ambulatory Patient Isolation Unit (PIU) designed to prevent chemical and particulate (biological and radiological) crosscontamination between an enclosed contaminated patient and the external environment during evacuation and transport activities.
Descriptive Summary of Technological Characteristics:
The indications for use and principles of operation of the ORCA™ Patient Isolation Unit are essentially identical to those of the predicate device (CAPSULS™); however, the ORCATM device will additionally protect the external environment from a chemically contaminated patient. The unit is lighter in weight, and provides first responders with hoisting capability. Differences between the devices result primarily from technological advances, such as those in materials technology, which have occurred since the CAPSULS™ device was introduced in 2005.
5
Image /page/5/Picture/1 description: The image shows the logo for ISOVAC Products LLC. The logo is divided into two parts, with the left side featuring the word "ISOVAC" in bold, black letters, with the words "PRODUCTS LLC" in smaller letters below. The letters are surrounded by a green circle. The right side of the logo displays the words "ISOVAC Products LLC" in a larger, green font.
1306 Enterprise Drive, Unit C • 630-679-1740
| Differences between the predicate and proposed devices are shown in BOLD type. | ||
|---|---|---|
| PARAMETERS | PREDICATE DEVICE | PROPOSED DEVICE |
| INTENDED USE | The CAPSULS (Containment and | |
| Protection System Utilizing Life | ||
| Support) is a portable Patient | ||
| Isolation Unit (PIU) | ||
| It is intended for the transport of | ||
| patients while preventing | ||
| particulate (biological and | ||
| radiological) cross-contamination | ||
| between the patient and the | ||
| external environment. | ||
| PIU is designed with features that | ||
| enable medical intervention. | The Model ORCA-2016CN | |
| (Operational Rescue Containment | ||
| Apparatus) is a portable and | ||
| ambulatory Patient Isolation Unit | ||
| (PIU) | ||
| The Model ORCA-2016CN is a | ||
| portable and ambulatory Patient | ||
| Isolation Unit (PIU) designed to | ||
| prevent chemical and particulate | ||
| (biological and radiological) | ||
| cross-contamination between an | ||
| enclosed contaminated patient | ||
| and the external environment | ||
| during evacuation and transport | ||
| activities. | ||
| FRAMEWORK | Plastic resin stanchions and | |
| integral ribs | Plastic rib structure | |
| ENVELOPE | Zippered transparent flexible | |
| PVC or Polyurethane (PUR) | ||
| welded transparent film enclosure | Zippered GORE® CHEMPAK® | |
| SPM Fabric enveloped with | ||
| clear PVC viewing windows | ||
| LIFTING AND | ||
| TRANSPORT SUPPORT | The CAPSULS is intended for | |
| mounting on a standard | ||
| medical litter that can also be | ||
| lifted by a (PVC or PUR) | ||
| coated fabric mesh base mat | The ORCA is intended for | |
| mounting on a standard medical | ||
| litter or on a Stokes litter (not | ||
| supplied) during hoisting | ||
| operations that be lifted by a | ||
| 1306 Enterprise Drive, Unit C • Romeoville, IL 60446 • 630-679-1740 | ||
| with carry straps integral to | ||
| the product. | fabric mesh base mat with | |
| carry straps integral to the | ||
| product. | ||
| AIR SUPPLY BLOWER | C420, battery operated, | |
| military issue, commercial | ||
| (Powered Air Purifying | ||
| Respirator) blower | C420, battery operated, | |
| military issue, commercial | ||
| (Powered Air Purifying | ||
| Respirator) blower. | ||
| BLOWER POWER | ||
| SUPPLY AND | ||
| CONTROLS | One replaceable or | |
| rechargeable, 10-hour, 6VDC | ||
| battery. | ||
| Blower incorporates | ||
| ON/OFF switch | ||
| Low battery alarm | 6VDC battery options: | |
| #1: D-Cell battery pack | ||
| (standard) | ||
| #2: AA-Cell battery pack | ||
| #3: Rechargeable NiMH battery | ||
| #4: BA5800/U LiSO2 | ||
| Blower incorporates | ||
| ON/OFF switch | ||
| Low battery alarm | ||
| AIR FILTRATION | Two (2) M95, P100/HEPA | |
| (High Efficiency Particulate | ||
| Air) rated filter cartridges | Two (2) M96, P100/HEPA | |
| (High Efficiency Particulate | ||
| Air) rated filter cartridges | ||
| ROUGHING FILTERS | Integral with the M95 cartridges | |
| described above. | Integral with the M96 cartridges | |
| described above. | ||
| AIR FLOW CONTROL | Airflow from patient head to foot | |
| is set by the blower manufacturer | ||
| at 4 CFM. Air backflow is | ||
| prevented by check valves. | Airflow enters at the rights | |
| side of patient head and is | ||
| exhausted to the left of patient | ||
| head. Airflow rate is set by the | ||
| blower manufacturer at 4 | ||
| CFM. Air backflow is | ||
| prevented by a check valve. | ||
| PATIENT ANCILLARY | ||
| OXYGEN | Tubing ports compatible with | |
| oxygen tubing and mask (not | ||
| supplied) | No Tubing Ports | |
| LIFTING HANDLES | CAPSULS™ is designed to be | |
| mounted on and lifted with the | ||
| handles of a standard medical | ||
| litter. In the absence of a litter, | ||
| CAPSULS may be lifted with the | ORCA is designed to be | |
| mounted on and lifted with the | ||
| handles of a standard medical | ||
| litter or NATO or Stokes litter. | ||
| In the absence of a litter, | ||
| ORCA may be lifted with the | ||
| 1306 Enterprise Drive, Unit C • | ||
| Romeoville, IL 60446 • | ||
| 630-679-1740 | ||
| four integral carrying straps on | ||
| each side of the unit. | four integral carrying straps on | |
| each side of the unit. | ||
| ABSORBENT PAD | No Absorbent Pad | Internal Absorbent Pad |
| AIR CHANGES | 15-20 air changes per hour under | |
| normal use conditions. | 20-38 air changes per hour | |
| under normal use conditions. | ||
| DIMENSIONS | ||
| (with handles retracted) | ||
| Length | 78" envelope, 88" overall length | |
| with blower and stanchions | 81" overall length | |
| Width | 24 inches | 26 inches |
| Height | 18 inches | 20 inches |
| Storage Height | 15 inches | 10 inches |
| Storage Volume | Approximately 3 cubic feet | Approximately 4.2 cubic feet |
| Weight | 25 lbs. (polyurethane), 35 lbs. | |
| (PVC) | 21 lbs. |
6
Image /page/6/Picture/1 description: The image shows the logo for ISOVAC Products LLC. The logo features the company name in bold, black letters, with the "V" in "ISOVAC" stylized as an inverted triangle. A green circle surrounds the "ISO" portion of the name. Below the "VAC" portion, the words "PRODUCTS LLC" are written in a smaller, sans-serif font.
ISOVAC Products LLC
7
Image /page/7/Picture/1 description: The image contains the logo for ISOVAC Products LLC. On the left side of the image is the ISOVAC logo, which consists of the company name in bold black letters surrounded by a green circle. To the right of the logo, the company name is written out in green letters.
Performance Data:
Operation system testing was successfully conducted on the ORCA™ PIU by the U.S. Coast Guard. This operational testing included hoisting and transport of the PIU with the test platform being a MH-60 helicopter. The PIU was hoisted multiple times at various altitudes (25/50/75/100 ft.) using a trail line to stabilize the stokes litter (video documentation is on file with the USCG). The results from this performance testing, to the satisfaction of the USCG, validated the "proof of concept" for using the PIU in USCG aircraft. The MH-60 generates 90 plus knots of downward rotor wash during a hover and this was deemed by the
8
Image /page/8/Picture/1 description: The image shows the logo for ISOVAC Products LLC. The logo consists of the text "ISOVAC" in black, with the words "PRODUCTS LLC" in smaller green font below it, all enclosed in a green circle. To the right of the logo is the text "ISOVAC Products LLC" in a larger green font.
1306 Enterprise Drive, Unit C • • Romeoville, IL 60446 • 630-679-1740
USCG as sufficient testing as the PIU is intended to be a one time use piece of equipment. USCG Tactics, Techniques and Procedures (TTP) for operational use of the PIU clearly articulates this requirement/limitation of the PIU. This includes the maximum flight duration allowed, DECON, training and maintenance. While a small boat could be used for transport of the PIU, the current CONOP uses a helicopter as this is the most extreme condition and most likely in the event we are transporting a contaminated patient.
The predicate device was not designed for hoisting.
Performance system testing was successfully conducted on the ORCA™ PIU by a third-party testing party under contract with the USGC. This performance testing included Chemical Agent Permeation (HD (distilled mustard) and GD (soman)), Liquid Penetration / Pathogen Passage, Human Use Comfort, and Weight Lift Testing.
PIU system permeation testing was performed in principle to those methods described in Institute of Environmental Sciences and Technology IEST- RP-CC001.3 (Ref 2) and MIL-STD-282 Method 102.9.1 (Ref 3) and demonstrated a containment efficiency (%) for both aerosols at a maximum 0.3 micron particle size exceeded the objective requirement. Liquid Penetration / Pathogen Passage testing was performed using methods described in ASTM F1671/F1671M-13: Standard Test Method for Resistance of Materials Used in Protective Clothing to Penetration by Blood-Borne Pathogens Using Phi-X174 Bacteriophage Penetration as a Test System. No detectable bacteriophage in the assay titer (i.e., 0 PFU/mL) was considered passing. The Bag Seam, Sleeve Seam, and Window Seam three materials passed liquid penetration testing.
Human interface comfort testing was performed using a test participant (TP) while being contained in the PIU for four hours. The participant was exposed to a matrix of six (6) temperature and RH% environments ranging from 65-90°F and 40 - 90% in a wind speed of 4 mph. Internal PIU temperature, RH%, CO2 and O2 levels, as well patient vitals and comfort levels were monitored over the four-hour test duration. The TP's vital signs were stable for the duration of the test with no indication of any heat stress or health related issue. Additionally, the TP reported no significant problems throughout the duration of the test.
9
Image /page/9/Picture/1 description: The image shows the logo of ISOVAC Products LLC. The logo consists of the company name in a green font. To the left of the company name is a circular graphic with the letters ISOVAC inside.
1306 Enterprise Drive, Unit C • 630-679-1740
The PIU weight lift capacity was tested under ISOVAC standard protocol procedure. The testing demonstrated the PIU handle strapping can hold the maximum test load of 480lb or a load of 137% of the stated maximum.
Conclusion:
The conclusions drawn from the nonclinical and clinical tests that demonstrate that the device is as safe, as effective, and performs as well as or better than the legally marketed device identified as the CAPSUL Patient Isolation Unit, cleared under the 510(k) submission number K052798.